YUT-27753-30046
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Registered in v-safe
- 2021-04-05
-
2021-04-06
Survey response — days 1–6 daily, dose 1MedDRA: Sensitive skin — Feeling: FairFree text: Skin more sensitive to capillary burst (raspberries) in response to past pressure, not at the site of injection (unclear whether related to vaccine effects)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
-
2021-04-30
Health check-in — day 7, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-07
- 2021-05-14
- 2021-05-22
- 2021-05-30
-
2021-06-05
Survey response — day 42, dose 2MedDRA: Menstruation delayed — Feeling: GoodFree text: Period was more than a week late, unusual for meMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-23
-
2021-10-22
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pregnancy and associated nausea/fatigue/insomniaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Survey response — 12 months, dose 2MedDRA: Pregnancy, Symphysiolysis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Pelvic symphysis dysfunction during pregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Skin more sensitive to capillary burst (raspberries) in response to past pressure, not at the site of injection (unclear whether related to vaccine effects)
Release 8 — day 42, dose 2
Symptoms: Period was more than a week late, unusual for me
Release 10 — 6 months, dose 2
Symptoms: Pregnancy and associated nausea/fatigue/insomnia
Release 11 — 12 months, dose 2
Symptoms: Pelvic symphysis dysfunction during pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Menstruation delayed | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Symphysiolysis | · | · | ✓ |
| SRO | Sensitive skin | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release